What is the principle of radiotherapy?

radiotherapy tolerance tests

SHORT VERSION

Radiation therapy is a localized treatment to kill cancer cells by irradiating them while sparing the surrounding normal tissue. The source of radiation can be outside (external radiotherapy) or inside (brachytherapy) the body.

 

During irradiation, the X-rays enter the cells where they produce physicochemical reactions that damage the cell DNA, causing the death or preventing the multiplication of such cells. Therefore, the radiation must be directed very precisely to the area to be treated, to preserve as much as possible the healthy tissues and the surrounding organs, which are called “organs at risk”. Moreover, radiation outcomes will be different in cancer and normal cells. Indeed, normal cells can often manage to repair DNA damage between radiotherapy sessions and they will survive, but not cancer cells that are also more sensitive to irradiation and will be killed during treatment.

The key parameters of radiotherapy are the:

    • Total radiation dose(in Gray or Gy, the unit of prescription for radiotherapy)
    • Treatment duration (the total time between the first and last treatment session)
    • Dose fractionation (the total number of sessions)
    • Irradiated volume

Before treatment initiation, these different parameters will be optimally defined by the radiation oncologist. The total radiation dose will be chosen in function of the tumor type (some cancers are more “radiosensitive” than others) and on the tolerance of the surrounding organs.

 

Notez cet post

FIRST TESTS TO PREDICT A PATIENT’S RADIOSENSITIVITY

NovaGray develops and commercializes the first radiotherapy tolerance tests for patients treated for breast or prostate cancer.

Performed before the start of radiotherapy with a simple blood draw, the tests assess the patients’ individual radiosensitivity and determine their risk of developing late complications after radiotherapy.

WHY DO A RADIOSENSITIVITY TEST?

Knowing a patient’s individual radiosensitivity is important information that can help:

  • Reassure the patient in preparation for radiotherapy
  • Guide physicians in choosing the most appropriate treatment plan
  • Adapt patient follow-up after radiotherapy

Team NovaGray

NovaGray develops radiotherapy tolerance tests for breast and prostate cancer patients. NovaGray's mission is to help personalize cancer treatment by assessing each patient's individual sensitivity before starting radiotherapy. NovaGray technology has been validated by multi-center prospective clinical trials. NovaGray tests are recommended by the French Society of Radiation Oncology (SFRO).